Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: Possible role in microvesicular steatosis induced by this antibiotic

Hepatology

Volumn 8, Issue 5, 1988, Pages 1056-1062

  Fréneaux, Eric ^a   Labbe, Gilles ^a   Letteron, Philippe ^a   Dinh, The Le ^a   Degott, Claude ^a   Genève, Jean ^a   Larrey, Dominique ^a   Pessayre, Dominique ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; KETONE BODY; TETRACYCLINE;

ANIMAL CELL; CLINICAL ARTICLE; FATTY ACID OXIDATION; HUMAN; HUMAN CELL; LIVER MITOCHONDRION; PRIORITY JOURNAL; STEATOSIS;

ANIMAL; BIOPSY; CELLS, CULTURED; DEPRESSION, CHEMICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS; FATTY LIVER; HUMAN; LIPIDS; LIVER; MALE; MICE; MITOCHONDRIA, LIVER; OXIDATION-REDUCTION; TETRACYCLINE; TIME FACTORS;

EID: 0023706706     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840080513     Document Type: Article

References (38)

1. Tetracycline and incorporation of amino acids into proteins of rat tissues
2. Tetracycline‐induced fatty liver. Biochemical mechanisms (Abstract)
3. Impaired secretion of triglycerides by the liver. A cause of tetracycline induced fatty liver
4. The effect of tetracycline on the hepatic secretion of triglyceride
5. Fatty liver induced by tetracycline in the rat. Dose‐response relationships and effect of sex
6. 14C]oleate by the liver
7. Comparative effects of tetracycline and doxycycline on liver function of young adult and old mice
8. Valproate‐induced hepatic injury: analyses of 23 fatal cases
9. Hypoglycin, the famous toxin of the unripe Jamaican ackee fruit
10. Production of the features of Reye's syndrome in rats with 4‐pentenoic acid
11. Pirprofen‐induced fulminant hepatitis
12. The hepatotoxicity of valproic acid and its metabolites. I. Toxicologic, biochemical and histopathologic studies
13. Mechanisms of the metabolic disturbances caused by hypoglycin and by pent‐4‐enoic acid. In vitro studies
14. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid‐induced fatty liver. A possible model for Reye's syndrome
15. Inhibition of mitochondrial β‐oxidation of fatty acids by pirprofen. Role in microvesicular steatosis due to this nonsteroidal anti‐inflammatory drug
16. Carnitine palmitoyl‐transferase I. The site of inhibition of hepatic fatty acid oxidation by malonyl‐CoA
17. Protein measurement with the Folin phenol reagent
18. Activation of mitochondrial fatty acid oxidation by calcium. Conversion to the energized state
19. Factors controlling the rate of fatty acid β‐oxidation in rat liver mitochondria
20. Commentary on the mechanisms of some pharmacological actions of the hypoglycaemic toxins hypoglycin and pent‐4‐enoic acid. A way out of the present confusion
21. 14C]palmitate oxidation, triacylglycerol synthesis and secretion in isolated hepatocytes
22. Enzymatic determination of D(‐)‐β‐hydroxybutyric acid and acetoacetic acid in blood
23. Ketone body metabolism in the ketosis of starvation and alloxan diabetes
24. A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases
25. Enzymatische Harnstoffbestimmung in Blut und Serum im optischen Test nach Warburg
26. Selective localization of tetracycline in mitochondria of living cells
27. 13) dicarboxylic acids
28. Fatty acid uncoupling of oxidative phosphorylation in rat liver mitochondria
29. Reye's syndrome: current concepts
30. Tetracycline toxicity in pregnancy. Liver and pancreatic dysfunction
31. Hepatic uptake and biliary excretion of tetracycline in the rat
32. Effects of tetracycline on ultrastructure and lipoprotein secretion in the rat hepatocyte
33. Pharmacotherapeutics of the newer tetracyclines
34. Blood and organ concentrations of tetracycline and doxycycline in female mice. Comparison to males
35. Glutaric acidemia type II: clinical, biochemical, and morphologic considerations
36. Medium‐chain and long‐chain acyl CoA dehydrogenase deficiency: clinical, pathologic and ultrastructural differentiation from Reye's syndrome
37. Familial Reye‐like syndrome: a presentation of medium‐chain acyl‐coenzyme A dehydrogenase deficiency